Emerging Infectious Diseases

View more issues:

Articles in June, 2005 issue of Emerging Infectious Diseases

• Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of Congo, 1982-2001
  by Jacques Pepin
• Antimicrobial resistance determinants and future control
  by Stephan Harbarth
• Methicillin-resistant—Staphylococcus aureus hospitalizations, United States
  by Matthew J. Kuehnert
• Free-living Canada Geese and antimicrobial resistance
  by Dana Cole
• Community acquired methicillin-resistant Staphylococcus aureus, Uruguay
  by Xiao Xue Ma
• Diversification in Salmonella Typhimurium DT104
  by John Threlfall
• pVir and bloody diarrhea in Campylobacter jejuni enteritis
  by Dobryan M. Tracz
• Impact of statewide program to promote appropriate antimicrobial drug use
  by Edward A. Belongia
• Tuberculosis due to resistant Haarlem strain, Tunisia
  by Helmi Mardassi
• Emergence and spread of Streptococcus pneumoniae with erm and mef resistance
  by David J. Farrell
• Methicillin-resistant Staphylococcus aureus in community-acquired skin infections
  by Gregory J. Moran
• Community-associated methicillin-resistant Staphylococcus aureus in pediatric patients
  by Theresa J. Ochoa
• Community-associated methicillin-resistant Staphylococcus aureus, Canada
  by Michael R. Mulvey
• Community-associated methicillin-resistant Staphylococcus aureus, Switzerland
  by Stephan Harbarth
• An emptying quiver: antimicrobial drugs and resistance
  by J. Todd Weber
• International Salmonella Typhimurium DT104 infections, 1992-2001
  by Morten Helms
• Rifampicin resistance in tuberculosis outbreak, London, England
  by Claire Jenkins
• Erythromycin-nonsusceptible Streptococcus pneumoniae in children, 1999-2001
  by M. Catherine McEllistrem
• Community prescribing and resistant Streptococcus pneumoniae
  by Galia Barkai
• Clinician knowledge and beliefs after statewide program to promote appropriate antimicrobial drug use
  by Karen M. Kiang
• armA and aminoglycoside resistance in Escherichia coli
  by Bruno Gonzalez-Zorn
• Drugs, microbes, and antimicrobial resistance
  by Polyxeni Potter
• Extended-spectrum [beta]-lactamase-producing flora in healthy persons
  by Camilla Rodrigues
• Antimicrobial resistance in Campylobacter
  by Louis Anthony Cox, Jr.
• Hidden epidemic of macrolide-resistant pneumococci
  by Keith P. Klugman
• Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs
  by John M. Stelling
• Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003
  by Surbhi Malhotra-Kumar
• Correction: vol. 11, no. 5
• Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex
  by Rob J.L. Willems
• Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in rural communities, Western United States
  by Kurt B. Stevenson
• Global spread of multiple aminoglycoside resistance genes
  by Kunikazu Yamane
• Quinolone safety and efficacy
  by Spartaco Bellomo
• Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units
  by Simona Bratu
• Nonprescribed antimicrobial drugs in Latino community, South Carolina
  by Arch G. Mainous, III
• Hospitalization and antimicrobial resistance in Salmonella outbreaks, 1984-2002
  by Jay K. Varma
• Rifampin-resistant meningococcal disease
  by Jean Rainbow
• Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae
  by Crystal N. Johnson
• Fluoroquinolone-resistant Escherichia coli carriage in long-term care facility
  by Joel N. Maslow
• Cephalosporin and ciprofloxacin resistance in Salmonella, Taiwan
  by Jing-Jou Yan
• Upcoming infectious disease activities
• Measuring impact of antimicrobial resistance
  by Mary-Claire Roghmann